Edward Benz

Director at F-star Biotechnology

Dr. Benz joined the F-star Board of Directors in December 2019 and is a renowned leader in the field of hematology/oncology with a distinguished career spanning more than 40 years across industry and academia. Dr. Benz has been President and Chief Executive Officer Emeritus of the Dana-Farber Cancer Institute, Boston, MA since October 2016. He has also served as the Richard and Susan Smith Distinguished Professor of Medicine, Professor of Pediatrics, Professor of Genetics, and Faculty Dean Emeritus for Oncology at Harvard Medical School since November 2000. Former associate editor of the New England Journal of Medicine, and co-editor of prize-winning textbooks, Dr. Benz has authored over 300 peer-reviewed publications and holds several senior positions on various academic and biotech boards. He received his Doctor of Medicine from Harvard Medical School (magna cum laude) and holds an M.A. from Yale University (ad privatum) and a B.A. (cum laude) from Princeton University.

Timeline

  • Director

    Current role